Brought to you by 
AHP pays Biomatrix $23mm forSynvisc rights; sells back
09 Nov 2004
Executive Summary
In a deal worth $23mm to Biomatrix (viscoelastic biomedical products), American Home Product's Wyeth-Ayerst Laboratories division gains marketing rights to Synvisc, an osteoarthritis knee treatment, in the US and several other territories.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Medical Devices
- Biomaterials
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Contract
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com